Identification of TNF-α-responsive NF-κB p65-binding element in the distal promoter of the mouse serine protease inhibitor SerpinE2

FEBS Letters

Volumn 580, Issue 13, 2006, Pages 3257-3262

  Suzuki, Shunsuke ^a   Singhirunnusorn, Pattama ^a   Nakano, Hiroyasu ^b   Doi, Takahiro ^c   Saiki, Ikuo ^a   Sakurai, Hiroaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

Murine embryonic fibroblast; Nuclear factor B p65 subunit; Serine protease inhibitor, clade E, member 2; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN SERPINE2; SERINE PROTEINASE INHIBITOR; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL NUCLEUS; FIBROBLASTS; GENE EXPRESSION; I-KAPPA B KINASE; MICE; PROMOTER REGIONS (GENETICS); PROTEIN TRANSPORT; RESPONSE ELEMENTS; RNA, MESSENGER; SERPINS; THIOPHENES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 33646559847     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.04.086     Document Type: Article

References (36)

1. Karin M., and Ben Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18 (2000) 621-663
2. Silverman N., and Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15 (2001) 2321-2342
3. Baldwin Jr. A.S. Series introduction: the transcription factor NF-κB and human disease. J. Clin. Invest. 107 (2001) 3-6
4. Tak P.P., and Firestein G.S. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107 (2001) 7-11
5. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107 (2001) 241-246
6. Ghosh S., and Karin M. Missing pieces in the NF-κB puzzle. Cell 109 Suppl. (2002) S81-S96
7. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., and Karin M. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16 (1996) 1295-1304
8. Rodriguez M.S., Wright J., Thompson J., Thomas D., Baleux F., Virelizier J.L., Hay R.T., and Arenzana-Seisdedos F. Identification of lysine residues required for signal-induced ubiquitination and degradation of IκBα in vivo. Oncogene 12 (1996) 2425-2435
9. Roff M., Thompson J., Rodriguez M.S., Jacque J.M., Baleux F., Arenzana-Seisdedos F., and Hay R.T. Role of IκBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem. 271 (1996) 7844-7850
10. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388 (1997) 548-554
11. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., and Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278 (1997) 860-866
12. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., and Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93 (1998) 1231-1240
13. Mercurio F., Murray B.W., Shevchenko A., Bennett B.L., Young D.B., Li J.W., Pascual G., Motiwala A., Zhu H., Mann M., and Manning A.M. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19 (1999) 1526-1538
14. Tanaka K., Kawakami T., Tateishi K., Yashiroda H., and Chiba T. Control of IκBα proteolysis by the ubiquitin-proteasome pathway. Biochimie 83 (2001) 351-356
15. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., and Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91 (1997) 243-252
16. Baker J.B., Low D.A., Simmer R.L., and Cunningham D.D. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21 (1980) 37-45
17. Reinhard E., Meier R., Halfter W., Rovelli G., and Monard D. Detection of glia-derived nexin in the olfactory system of the rat. Neuron 1 (1988) 387-394
18. Vaughan P.J., and Cunningham D.D. Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J. Biol. Chem. 268 (1993) 3720-3727
19. Mbebi C., Hantai D., Jandrot Perrus M., Doyennette M.A., and Verdiere Sahuque M. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J. Cell Physiol. 179 (1999) 305-314
20. Okazaki T., Sakon S., Sasazuki T., Sakurai H., Doi T., Yagita H., Okumura K., and Nakano H. Phosphorylation of serine 276 is essential for p65 NF-κB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300 (2003) 807-812
21. Doi T.S., Takahashi T., Taguchi O., Azuma T., and Obata Y. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185 (1997) 953-961
22. Sakurai H., Kurusu R., Sano K., Tsuchiya T., and Tsuda M. Stimulation of cultured cerebellar granule cells via glutamate receptors induces TRE- and CRE-binding activities mediated by common DNA-binding complexes. J. Neurochem. 59 (1992) 2067-2075
23. Kishore N., Sommers C., Mathialagan S., Guzova J., Yao M., Hauser S., Huynh K., Bonar S., Mielke C., Albee L., Weier R., Graneto M., Hanau C., Perry T., and Tripp C.S. A selective IKK-2 inhibitor blocks NF-κB-dependent gene expression in interleukin-1β-stimulated synovial fibroblasts. J. Biol. Chem. 278 (2003) 32861-32871
24. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev. 18 (2004) 2195-2224
25. Hasina R., Hulett K., Bicciato S., Di Bello C., Petruzzelli G.J., and Lingen M.W. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Res. 63 (2003) 555-559
26. Yoshino H., Endo Y., Watanabe Y., and Sasaki T. Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br. J. Cancer 78 (1998) 833-839
27. Duggan C., Kennedy S., Kramer M.D., Barnes C., Elvin P., McDermott E., O'Higgins N., and Duffy M.J. Plasminogen activator inhibitor type 2 in breast cancer. Br. J. Cancer 76 (1997) 622-627
28. Buchholz M., Biebl A., Neebetae A., Wagner M., Iwamura T., Leder G., Adler G., and Gress T.M. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res. 63 (2003) 4945-4951
29. Mueller B.M., Yu Y.B., and Laug W.E. Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc. Natl. Acad. Sci. USA 92 (1995) 205-209
30. Kruithof E.K., Baker M.S., and Bunn C.L. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86 (1995) 4007-4024
31. Cousin E., Medcalf R.L., Bergonzelli G.E., and Kruithof E.K. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res. 19 (1991) 3881-3886
32. Dear A.E., Costa M., and Medcalf R.L. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA. FEBS Lett. 402 (1997) 265-272
33. Guttridge D.C., and Cunningham D.D. Characterization of the human protease nexin-1 promoter and its regulation by Sp1 through a G/C-rich activation domain. J. Neurochem. 67 (1996) 498-507
34. Mahony D., Kalionis B., and Antalis T.M. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-κB-like transcriptional regulatory motif. Eur. J. Biochem. 263 (1999) 765-772
35. Hou B., Eren M., Painter C.A., Covington J.W., Dixon J.D., Schoenhard J.A., and Vaughan D.E. Tumor necrosis factor α activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor κB site. J. Biol. Chem. 279 (2004) 18127-18136
36. Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., and Saiki I. Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278 (2003) 36916-36923